GALT · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2020-11-09 compared with 2020-08-10 · 2 added, 3 removed, 23 unchanged (18% of the section changed)
17 unchanged sentences
Furnished herewith and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on August 10, 2020.
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on November 9, 2020.
GALECTIN THERAPEUTICS INC.
−Removed: /s/ Harold H.
−Removed: Shlevin, Ph.D.
+Added: /s/ Joel Lewis
Chief Executive Officer and President
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.